{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:13:48Z","timestamp":1776122028555,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["21171167"],"award-info":[{"award-number":["21171167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30973567"],"award-info":[{"award-number":["30973567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31370737"],"award-info":[{"award-number":["31370737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.actbio.2015.05.017","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T16:21:40Z","timestamp":1432311700000},"page":"116-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging"],"prefix":"10.1016","volume":"23","author":[{"given":"Xiaolei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jincan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2015.05.017_b0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc1894","article-title":"Photodynamic therapy and anti-tumour immunity","volume":"6","author":"Castano","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2015.05.017_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/1011-1344(96)07342-3","article-title":"Photodynamic therapy: a promising new modality for the treatment of cancer","volume":"34","author":"Schuitmaker","year":"1996","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.actbio.2015.05.017_b0015","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/eye.2014.134","article-title":"Photodynamic therapy for central serous chorioretinopathy","volume":"28","author":"Erikitola","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.actbio.2015.05.017_b0020","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/eye.2012.66","article-title":"Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"26","author":"Uetani","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.actbio.2015.05.017_b0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1572-1000(06)00035-4","article-title":"Topical photodynamic therapy for non-cancerous skin conditions","volume":"3","author":"Mitra","year":"2006","journal-title":"Photodiag. Photodyn. Therapy"},{"key":"10.1016\/j.actbio.2015.05.017_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10847-010-9918-x","article-title":"Synthesis and properties of photo-activable phthalocyanines: a brief overview","volume":"71","author":"Wang","year":"2011","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1039\/b513219c","article-title":"Physical and chemical properties of pyropheophorbide-a methyl ester in ethanol, phosphate buffer and aqueous dispersion of small unilamellar dimyristoyl-L-\u03b1-phosphatidylcholine vesicles","volume":"5","author":"Delanaye","year":"2006","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.actbio.2015.05.017_b0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1751-1097.1996.tb02442.x","article-title":"Alkyl ether analogs of chlorophyll-a derivatives: part 1. Synthesis, photophysical properties and photodynamic efficacy","volume":"64","author":"Pandey","year":"1996","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.actbio.2015.05.017_b0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1385272033373076","article-title":"Synthesis, photophysical and photochemical aspects of phthalocyanines for photodynamic therapy","volume":"7","author":"Tedesco","year":"2003","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.7150\/thno.8527","article-title":"A novel tumor targeting drug carrier for optical imaging and therapy","volume":"4","author":"Li","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2015.05.017_b0055","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.actbio.2014.06.026","article-title":"Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy","volume":"10","author":"Chen","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2015.05.017_b0060","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1021\/bc200242v","article-title":"In vivo detection of phospholipase C by enzyme-activated near-infrared probes","volume":"22","author":"Mawn","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0065","first-page":"507","article-title":"Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents","volume":"4","author":"Anikeeva","year":"2014","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.actbio.2015.05.017_b0070","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/mp200590y","article-title":"Pyropheophorbide A and c(RGDyK) comodified chitosan-wrapped upconversion nanoparticle for targeted near-infrared photodynamic therapy","volume":"9","author":"Zhou","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2015.05.017_b0075","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2015.05.017_b0080","first-page":"15","article-title":"Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers","volume":"20","author":"Vokes","year":"2006","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.actbio.2015.05.017_b0085","first-page":"2958","article-title":"A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor","volume":"7","author":"Ciardiello","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2015.05.017_b0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2011.09.012","article-title":"EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies","volume":"8","author":"Master","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.actbio.2015.05.017_b0095","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1021\/mp300256e","article-title":"Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers","volume":"9","author":"Master","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2015.05.017_b0100","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"UPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.actbio.2015.05.017_b0105","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2174\/138945011797635812","article-title":"Rational targeting of the urokinase receptor (uPAR): development of antagonists and non-invasive imaging probes","volume":"12","author":"Kriegbaum","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.actbio.2015.05.017_b0110","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2174\/1381612033454630","article-title":"Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor","volume":"9","author":"Ploug","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.actbio.2015.05.017_b0115","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1121143","article-title":"Structure of human urokinase plasminogen activator in complex with its receptor","volume":"311","author":"Huai","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.actbio.2015.05.017_b0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nsmb.1404","article-title":"Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes","volume":"15","author":"Huai","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.actbio.2015.05.017_b0125","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1158\/1078-0432.CCR-08-3289","article-title":"Receptor-targeted nanoparticles for in vivo imaging of breast cancer","volume":"15","author":"Yang","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2015.05.017_b0130","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1074\/jbc.M109.093492","article-title":"Structure-based engineering of species selectivity in the interaction between urokinase and its receptor: implication for preclinical cancer therapy","volume":"285","author":"Lin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pep.2006.05.005","article-title":"Protein expression and preliminary crystallographic analysis of amino-terminal fragment of urokinase-type plasminogen activator","volume":"49","author":"Zhao","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.actbio.2015.05.017_b0140","first-page":"277","article-title":"The expression, purification and crystallization of monomeric soluble human urokinase receptor","volume":"33","author":"Yuan","year":"2006","journal-title":"Prog. Biochem. Biophys."},{"key":"10.1016\/j.actbio.2015.05.017_b0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.inoche.2005.12.002","article-title":"Derivatizable phthalocyanine with single carboxyl group: synthesis and purification","volume":"9","author":"Chen","year":"2006","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.actbio.2015.05.017_b0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15216540500404093","article-title":"The extraordinary ligand binding properties of human serum albumin","volume":"57","author":"Fasano","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.actbio.2015.05.017_b0155","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actbio.2015.05.017_b0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.actbio.2015.05.017_b0165","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1158\/1535-7163.MCT-06-0315","article-title":"A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types","volume":"5","author":"Abi-Habib","year":"2006","journal-title":"Mol. Cancer Therapy"},{"key":"10.1016\/j.actbio.2015.05.017_b0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1572-1000(05)00060-8","article-title":"Mechanisms in photodynamic therapy: part three\u2014photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction","volume":"2","author":"Castano","year":"2005","journal-title":"Photodiag. Photodyn. Therapy"},{"key":"10.1016\/j.actbio.2015.05.017_b0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jps.2600840209","article-title":"Pharmacokinetics and body distribution of liposomal zinc phthalocyanine in tumor-bearing mice. influence of aggregation state, particle size, and composition","volume":"84","author":"Isele","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2015.05.017_b0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.yrtph.2006.06.006","article-title":"Intravenous repeated-dose toxicity study of ZnPcS2P2-based-photodynamic therapy in beagle dogs","volume":"47","author":"Liu","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.actbio.2015.05.017_b0185","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1039\/b605516h","article-title":"Intravenous repeated-dose toxicity study of ZnPcS2P2-based-photodynamic therapy in wistar rats","volume":"5","author":"Zhang","year":"2006","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.actbio.2015.05.017_b0190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11094-005-0150-8","article-title":"Efficiency and pharmacokinetics of photosense: a new liposomal photosensitizer formulation based on aluminum sulfophthalocyanine","volume":"39","author":"Smirnova","year":"2005","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.actbio.2015.05.017_b0195","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/cmdc.201000042","article-title":"Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy","volume":"5","author":"Chen","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0200","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/bc100070g","article-title":"Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects","volume":"21","author":"Maeda","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0205","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2015.05.017_b0210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2967\/jnumed.110.083998","article-title":"Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system","volume":"52","author":"Heneweer","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.actbio.2015.05.017_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.actbio.2015.05.017_b0220","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5414\/CPP48453","article-title":"Albumin, a versatile carrier in oncology","volume":"48","author":"Kratz","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Therapy"},{"key":"10.1016\/j.actbio.2015.05.017_b0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Control Release"},{"key":"10.1016\/j.actbio.2015.05.017_b0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-3233(08)60065-0","article-title":"Serum albumin","volume":"37","author":"Peters","year":"1985","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Kragh-Hansen","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.actbio.2015.05.017_b0240","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/S0021-9258(19)41721-3","article-title":"Long chain fatty acid binding to human plasma albumin","volume":"250","author":"Ashbrook","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0245","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1073\/pnas.1137188100","article-title":"Structural basis of albumin\u2013thyroxine interactions and familial dysalbuminemic hyperthyroxinemia","volume":"100","author":"Petitpas","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actbio.2015.05.017_b0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6807-3-6","article-title":"Crystal structural analysis of human serum albumin complexed with hemin and fatty acid","volume":"3","author":"Zunszain","year":"2003","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.actbio.2015.05.017_b0255","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.bmc.2004.03.073","article-title":"Paclitaxel\u2013HSA interaction. Binding sites on HSA molecule","volume":"12","author":"Trynda-Lemiesz","year":"2004","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0260","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/0006-2952(93)90577-J","article-title":"Study of interaction of carprofen and its enantiomers with human serum albumin\u2014II: stereoselective site-to-site displacement of carprofen by ibuprofen","volume":"46","author":"Rahman","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.actbio.2015.05.017_b0265","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.saa.2003.08.003","article-title":"Chlorpromazine interactions to sera albumins: a study by the quenching of fluorescence","volume":"60","author":"Silva","year":"2004","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.actbio.2015.05.017_b0270","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/157489209789206869","article-title":"Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery","volume":"4","author":"Fu","year":"2009","journal-title":"Rec. Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.actbio.2015.05.017_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14740338.2014.910193","article-title":"Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications","author":"Kudlowitz","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.actbio.2015.05.017_b0280","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/01.sla.0000171866.45848.68","article-title":"Osteonectin influences growth and invasion of pancreatic cancer cells","volume":"242","author":"Guweidhi","year":"2005","journal-title":"Ann. Surg."},{"key":"10.1016\/j.actbio.2015.05.017_b0285","first-page":"23","article-title":"Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium","volume":"15","author":"Schnitzer","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.actbio.2015.05.017_b0290","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1016\/S0021-9258(18)83652-3","article-title":"Endothelial albumin binding proteins are membrane-associated components exposed on the cell surface","volume":"264","author":"Ghinea","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0295","doi-asserted-by":"crossref","first-page":"24544","DOI":"10.1016\/S0021-9258(18)35799-5","article-title":"Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism","volume":"267","author":"Schnitzer","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0300","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1016\/S0021-9258(17)37571-3","article-title":"Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins","volume":"269","author":"Schnitzer","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2015.05.017_b0305","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1016\/S0021-9258(18)53212-9","article-title":"High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors","volume":"268","author":"Schnitzer","year":"1993","journal-title":"J. Biol. Chem."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270611500241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270611500241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:44:06Z","timestamp":1761669846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S174270611500241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":61,"alternative-id":["S174270611500241X"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2015.05.017","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2015.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}